Skip to main content
PharmaCielo Ltd. logo

PharmaCielo Ltd. — Investor Relations & Filings

Ticker · PCLO ISIN · CA71716K1012 LEI · 5493002XOFWMT83TYQ57 TSXV Manufacturing
Open in API
Filings indexed 389 across all filing types
Latest filing 2020-04-04 Regulatory Filings
Country CA Canada
Listing TSXV PCLO

About PharmaCielo Ltd.

https://www.pharmacielo.com/

PharmaCielo Ltd. is a global supplier specializing in the cultivation, processing, and distribution of medicinal-grade cannabis extracts and dried flower. The company focuses on ethical and sustainable production, aiming to be a leading partner in the global medicinal cannabis market. Utilizing ideal equatorial conditions, PharmaCielo operates large-scale, high-efficiency production facilities, including 12 hectares of open-air greenhouses, enabling four full crops annually for reliable supply. Its product portfolio includes standardized extracts, such as high-purity CBD Isolate, and both psychoactive and non-psychoactive derivatives. Production adheres to pharmaceutical-quality standards, supported by proprietary genetics maintained in a tissue culture lab and advanced processing facilities ensuring consistency and safety.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Regulatory Filings
2020-04-04 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a "best efforts" private placement offering of special warrants by PharmaCielo Ltd. It details the terms of the offering, including pricing, subscription agreements, use of proceeds, lock-up agreements, commissions to agents, regulatory approvals, and forward-looking statements. There is no financial report, earnings data, or management discussion of financial results. The document is clearly an announcement of a capital raising activity, specifically a private placement offering, which fits the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed information about the financing terms, not just a brief mention or a report publication announcement. Therefore, the appropriate classification is CAP with high confidence.
2020-04-01 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release from PharmaCielo Ltd. addressing an independent investigation into allegations made by a short seller. It discusses the appointment of an independent lead director, the scope and findings of the independent review, management commentary, and forward-looking statements. The document does not contain financial statements or detailed financial data but rather is a regulatory announcement responding to external claims and providing an update on the company's position and upcoming financial reporting. It references the upcoming Q4-2019 and fiscal 2019 financial results to be reported later, indicating this is not the financial report itself. The document is a regulatory announcement or general corporate update rather than a formal financial report or earnings release. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2020-03-23 English
News release - English.pdf
Notice of Dividend Amount Classification · 95% confidence The document is a press release announcing the declaration of a quarterly dividend and the adoption of a Dividend Reinvestment and Share Purchase Plan (DRIP) by Alamos Gold Inc. It includes details about the dividend amount, payment date, eligibility, and the mechanics of the DRIP. There are no financial statements or comprehensive financial data presented, nor is this a report or filing of financial results. The document is primarily an announcement related to dividend payments and shareholder options for reinvestment. According to the filing definitions, announcements about dividend amounts and payment details fall under the category 'Notice of Dividend Amount (DIV)'. The document length is 3637 characters, which is consistent with an announcement rather than a full report. Therefore, the appropriate classification is DIV with high confidence.
2020-03-03 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release issued by PharmaCielo Ltd. addressing a misleading short seller report. It contains forward-looking statements about the company's business progress, sales agreements, production targets, and upcoming financial results. It does not contain actual financial statements or detailed financial data. It is primarily a corporate communication responding to market rumors and providing operational updates. There is no indication that this is a full financial report, earnings release, or regulatory filing. The document is a public statement or announcement rather than a formal report or transcript. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements and corporate statements that do not fit other categories.
2020-03-03 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a three-year supply agreement between PharmaCielo and XPhyto Therapeutics Corp. It details the terms of the agreement, product types, regulatory approvals needed, and forward-looking statements about expected revenues and approvals. There are no financial statements, quarterly or annual results, nor is this a transcript of a call or a regulatory filing. It is a corporate announcement about a commercial agreement and financing terms (warrants and convertible debentures) related to the agreement. This fits best under Capital/Financing Update (CAP) because it involves financing activities (warrants, convertible debentures) and a significant commercial contract impacting capital structure and future revenues. The document length and content do not indicate it is a full financial report or regulatory filing. Therefore, the classification is CAP with high confidence.
2020-01-27 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.